src="https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tWDG-8W5mQd4OfTbVH96YvZ0eCh5XbUVbgjrmXL8rJfrQ6i57sCSTKkt2yq4B0Scv3l2-AiF1r6ctcUwVOCNp5ooKD8nyvX_FmCr6DrqIOWf9pGA7Phg=s0-d"> Grothey A, Sargent D: Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line
ERBITUX, as a single agent, is indicated for the treatment of EGFR-expressing metastatic colorectal cancer after failure of both irinotecan- and
E-mail : E-Mail
Search Engine : c-t-search.appspot.com
ctMedBrowser : More ctMedBrowser Info
Sponsor : Peta Software Promo
[Return to Medical Expert][Return to Cancer Expert]
ERBITUX, as a single agent, is indicated for the treatment of EGFR-expressing metastatic colorectal cancer after failure of both irinotecan- and For more information on each topic click the link(s) above.
You may also be interested in downloading ctMedBrowser for a unique viewing experience.
Contact
Web : http://c-t-search.infoE-mail : E-Mail
Search Engine : c-t-search.appspot.com
ctMedBrowser : More ctMedBrowser Info
Sponsor : Peta Software Promo
